| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.625 | 0.005 | 0.625 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.505 0.012 DBMET01621 0.519 0.011 DBMET01622 | ||
| 0.621 | 0.005 | 0.621 | Dyrk kinase inhibitor | 0.482 0.016 DBMET01621 0.498 0.014 DBMET01622 | ||
| 0.48 | 0.032 | 0.48 | GABA C receptor rho-3 antagonist | 0.341 0.091 DBMET01621 0.375 0.073 DBMET01622 | ||
| 0.455 | 0.058 | 0.455 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.277 0.246 DBMET01622 | ||
| 0.402 | 0.008 | 0.402 | Protein kinase (CK1) inhibitor | 0.116 0.095 DBMET01622 | ||
| 0.394 | 0.019 | 0.394 | RNA-directed DNA polymerase inhibitor | 0.252 0.048 DBMET01621 0.267 0.041 DBMET01622 | ||
| 0.362 | 0.005 | 0.362 | CDC-like kinase 1 inhibitor | 0.248 0.018 DBMET01621 0.255 0.017 DBMET01622 | ||
| 0.345 | 0.029 | 0.345 | Clk dual-specificity kinase inhibitor | 0.177 0.094 DBMET01621 0.177 0.093 DBMET01622 | ||
| 0.311 | 0.003 | 0.311 | Interferon agonist | 0.134 0.013 DBMET01621 0.144 0.011 DBMET01622 | ||
| 0.317 | 0.014 | 0.317 | Glycogen synthase kinase-3 inhibitor | 0.118 0.063 DBMET01621 0.125 0.058 DBMET01622 | ||
| 0.308 | 0.01 | 0.308 | Nitric-oxide synthase stimulant | 0.206 0.079 DBMET01621 0.207 0.078 DBMET01622 | ||
| 0.325 | 0.033 | 0.325 | Peroxidase inhibitor | 0.253 0.047 DBMET01621 0.25 0.047 DBMET01622 | ||
| 0.334 | 0.052 | 0.334 | Aryl hydrocarbon receptor agonist | 0.228 0.088 DBMET01621 0.215 0.094 DBMET01622 | ||
| 0.297 | 0.016 | 0.297 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.245 0.026 DBMET01621 0.257 0.024 DBMET01622 | ||
| 0.285 | 0.005 | 0.285 | Aurora-C kinase inhibitor | 0.256 0.009 DBMET01621 0.268 0.007 DBMET01622 | ||
| 0.277 | 0.016 | 0.277 | Glycogen synthase kinase-3 beta inhibitor | 0.118 0.063 DBMET01621 0.124 0.059 DBMET01622 | ||
| 0.265 | 0.008 | 0.265 | Aminoacyl-tRNA synthetase inhibitor | 0.163 0.016 DBMET01621 0.175 0.014 DBMET01622 | ||
| 0.277 | 0.021 | 0.277 | Glycogen synthase kinase-3 alpha inhibitor | 0.266 0.023 DBMET01621 0.266 0.023 DBMET01622 | ||
| 0.286 | 0.031 | 0.286 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.255 | 0.005 | 0.255 | Phosphodiesterase III inhibitor | |||
| 0.273 | 0.026 | 0.273 | I kappa B kinase epsilon inhibitor | 0.14 0.131 DBMET01621 0.161 0.108 DBMET01622 | ||
| 0.279 | 0.037 | 0.279 | CDC-like kinase 2 inhibitor | 0.154 0.09 DBMET01621 0.166 0.084 DBMET01622 | ||
| 0.255 | 0.013 | 0.255 | Ferrochelatase inhibitor | |||
| 0.244 | 0.004 | 0.244 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.214 0.005 DBMET01621 0.22 0.005 DBMET01622 | ||
| 0.239 | 0.005 | 0.239 | Folate antagonist | |||
| 0.235 | 0.003 | 0.235 | CDK5/p25 inhibitor | 0.042 0.027 DBMET01621 0.049 0.021 DBMET01622 | ||
| 0.234 | 0.003 | 0.234 | Interferon inducer | 0.099 0.013 DBMET01621 0.109 0.009 DBMET01622 | ||
| 0.237 | 0.016 | 0.237 | Cyclin-dependent kinase 5 inhibitor | 0.157 0.037 DBMET01621 0.162 0.034 DBMET01622 | ||
| 0.337 | 0.127 | 0.337 | 5 Hydroxytryptamine release inhibitor | 0.3 0.165 DBMET01621 0.298 0.167 DBMET01622 | ||
| 0.244 | 0.038 | 0.244 | MAP kinase kinase 3 inhibitor | |||
| 0.248 | 0.044 | 0.248 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.158 0.122 DBMET01621 0.159 0.121 DBMET01622 | ||
| 0.196 | 0.007 | 0.196 | Phenylalanine 4-hydroxylase inhibitor | 0.104 0.024 DBMET01621 0.119 0.019 DBMET01622 | ||
| 0.196 | 0.012 | 0.196 | HIV-1 integrase (Overall Integration) inhibitor | 0.123 0.038 DBMET01621 0.13 0.034 DBMET01622 | ||
| 0.194 | 0.018 | 0.194 | Check point kinase 2 inhibitor | |||
| 0.242 | 0.072 | 0.242 | DNA synthesis inhibitor | 0.178 0.157 DBMET01621 0.2 0.124 DBMET01622 | ||
| 0.204 | 0.037 | 0.204 | Cyclin-dependent kinase inhibitor | 0.099 0.091 DBMET01622 | ||
| 0.224 | 0.067 | 0.224 | MAP kinase kinase 2 inhibitor | |||
| 0.183 | 0.039 | 0.183 | GABA C receptor rho-2 antagonist | 0.132 0.101 DBMET01621 0.129 0.107 DBMET01622 | ||
| 0.157 | 0.014 | 0.157 | Raf kinase C inhibitor | |||
| 0.155 | 0.015 | 0.155 | MAP kinase kinase 1 inhibitor | 0.109 0.046 DBMET01621 0.117 0.038 DBMET01622 | ||
| 0.163 | 0.026 | 0.163 | Interleukin 8 antagonist | 0.13 0.05 DBMET01621 0.125 0.056 DBMET01622 | ||
| 0.174 | 0.039 | 0.174 | Protein kinase (CK1) delta inhibitor | |||
| 0.254 | 0.12 | 0.254 | Angiogenesis inhibitor | |||
| 0.206 | 0.072 | 0.206 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.166 | 0.034 | 0.166 | Protein kinase (CK2) alpha inhibitor | |||
| 0.17 | 0.041 | 0.17 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.292 | 0.164 | 0.292 | Calcium channel L-type activator | 0.279 0.175 DBMET01621 0.284 0.171 DBMET01622 | ||
| 0.171 | 0.042 | 0.171 | MAP kinase 3 inhibitor | |||
| 0.148 | 0.022 | 0.148 | Phosphodiesterase 7B inhibitor | |||
| 0.167 | 0.043 | 0.167 | MAP kinase kinase inhibitor | 0.104 0.09 DBMET01621 0.107 0.087 DBMET01622 | ||
| 0.176 | 0.054 | 0.176 | Protein kinase (CK1) gamma inhibitor | |||
| 0.152 | 0.03 | 0.152 | DNA repair enzyme inhibitor | |||
| 0.149 | 0.034 | 0.151 | Nav1.4 sodium channel blocker | 0.141 0.038 DBMET01621 0.151 0.033 DBMET01622 | DBMET01622 | |
| 0.189 | 0.073 | 0.189 | CDC-like kinase 4 inhibitor | |||
| 0.144 | 0.032 | 0.144 | MAP kinase 8 inhibitor | |||
| 0.123 | 0.011 | 0.123 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.053 0.044 DBMET01622 | ||
| 0.128 | 0.016 | 0.128 | Myeloperoxidase inhibitor | |||
| 0.142 | 0.03 | 0.142 | Pim-1 kinase inhibitor | |||
| 0.116 | 0.008 | 0.116 | Cyclin B1 inhibitor | 0.072 0.029 DBMET01621 0.076 0.026 DBMET01622 | ||
| 0.144 | 0.036 | 0.144 | GABA C receptor agonist | 0.108 0.059 DBMET01622 | ||
| 0.142 | 0.036 | 0.142 | Protein kinase C gamma inhibitor | 0.095 0.086 DBMET01621 | ||
| 0.113 | 0.007 | 0.113 | Cyclin B2 inhibitor | 0.075 0.018 DBMET01621 0.079 0.015 DBMET01622 | ||
| 0.142 | 0.036 | 0.142 | Protein kinase (CK2) inhibitor | |||
| 0.144 | 0.039 | 0.144 | 5 Hydroxytryptamine 3A agonist | 0.097 0.079 DBMET01621 0.091 0.088 DBMET01622 | ||
| 0.12 | 0.016 | 0.12 | Granulocyte macrophage colony stimulating factor agonist | 0.093 0.045 DBMET01621 0.089 0.054 DBMET01622 | ||
| 0.121 | 0.017 | 0.121 | mTOR complex 2 inhibitor | |||
| 0.128 | 0.025 | 0.128 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.148 | 0.05 | 0.148 | DNA polymerase I inhibitor | 0.105 0.081 DBMET01621 0.105 0.081 DBMET01622 | ||
| 0.106 | 0.009 | 0.106 | Factor IXa inhibitor | |||
| 0.105 | 0.009 | 0.105 | Cyclin B inhibitor | 0.067 0.024 DBMET01621 0.071 0.021 DBMET01622 | ||
| 0.113 | 0.023 | 0.113 | Check point kinase 1 inhibitor | |||
| 0.106 | 0.021 | 0.106 | CDC7 inhibitor | |||
| 0.121 | 0.036 | 0.121 | Electrolyte absorption antagonist | |||
| 0.097 | 0.012 | 0.097 | Glutamate (mGluR7) antagonist | 0.073 0.038 DBMET01621 0.071 0.041 DBMET01622 | ||
| 0.219 | 0.136 | 0.219 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.105 | 0.023 | 0.105 | CDK1/cyclin B inhibitor | |||
| 0.088 | 0.005 | 0.088 | Thymidylate synthase inhibitor | 0.048 0.031 DBMET01621 0.055 0.022 DBMET01622 | ||
| 0.131 | 0.049 | 0.131 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.107 | 0.026 | 0.107 | Cyclin B3 inhibitor | |||
| 0.12 | 0.04 | 0.12 | GABA C receptor rho-1 antagonist | |||
| 0.119 | 0.038 | 0.119 | DNA directed RNA polymerase inhibitor | |||
| 0.121 | 0.041 | 0.121 | CDK/cyclin complex inhibitor | |||
| 0.11 | 0.031 | 0.11 | MAP-kinase-activated kinase inhibitor | |||
| 0.198 | 0.122 | 0.198 | Interleukin agonist | |||
| 0.251 | 0.176 | 0.273 | Antibacterial | 0.25 0.177 DBMET01621 0.273 0.156 DBMET01622 | DBMET01622 | |
| 0.102 | 0.027 | 0.102 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.137 | 0.063 | 0.137 | Death-associated protein kinase 1 inhibitor | 0.13 0.081 DBMET01621 0.136 0.066 DBMET01622 | ||
| 0.146 | 0.072 | 0.146 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.171 | 0.1 | 0.29 | Pyruvate kinase inhibitor | 0.29 0.05 DBMET01621 0.267 0.056 DBMET01622 | DBMET01621 | |
| 0.124 | 0.053 | 0.124 | Polo-like kinase-4 inhibitor | |||
| 0.235 | 0.165 | 0.235 | Calcium channel activator | |||
| 0.088 | 0.019 | 0.088 | Phosphodiesterase VII inhibitor | |||
| 0.106 | 0.04 | 0.106 | Pim-3 kinase inhibitor | |||
| 0.12 | 0.055 | 0.12 | CDK3/cyclin E inhibitor | |||
| 0.113 | 0.05 | 0.113 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.081 | 0.018 | 0.081 | Cyclin D1 inhibitor | 0.064 0.037 DBMET01621 0.068 0.031 DBMET01622 | ||
| 0.088 | 0.025 | 0.088 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.169 | 0.107 | 0.169 | Platelet aggregation inhibitor | |||
| 0.154 | 0.092 | 0.154 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.089 | 0.027 | 0.089 | GABA B receptor agonist | 0.076 0.051 DBMET01621 0.082 0.038 DBMET01622 | ||
| 0.067 | 0.005 | 0.067 | Protein kinase (CK2) beta inhibitor | 0.039 0.013 DBMET01621 0.04 0.013 DBMET01622 | ||
| 0.207 | 0.146 | 0.207 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.088 | 0.027 | 0.088 | Secretase beta inhibitor | |||
| 0.07 | 0.01 | 0.07 | Histamine H2 receptor agonist | |||
| 0.098 | 0.04 | 0.098 | I kappa B kinase inhibitor | |||
| 0.08 | 0.024 | 0.103 | Xanthine dehydrogenase inhibitor | 0.103 0.015 DBMET01621 0.101 0.015 DBMET01622 | DBMET01621 | |
| 0.185 | 0.129 | 0.185 | DNA damaging | |||
| 0.108 | 0.053 | 0.108 | UDP-glucose 4-epimerase inhibitor | 0.088 0.076 DBMET01622 | ||
| 0.063 | 0.012 | 0.063 | Thymidine kinase inhibitor | |||
| 0.077 | 0.027 | 0.077 | Carbonic anhydrase stimulant | |||
| 0.091 | 0.043 | 0.091 | D-Ala-D-Ala ligase inhibitor | 0.091 0.042 DBMET01621 0.089 0.047 DBMET01622 | ||
| 0.174 | 0.126 | 0.174 | ErbB-1 antagonist | |||
| 0.087 | 0.038 | 0.133 | Histidine decarboxylase inhibitor | 0.122 0.025 DBMET01621 0.133 0.023 DBMET01622 | DBMET01622 | |
| 0.139 | 0.091 | 0.139 | Src kinase inhibitor | |||
| 0.111 | 0.063 | 0.111 | GABA C receptor antagonist | |||
| 0.055 | 0.008 | 0.055 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.058 | 0.012 | 0.058 | Dihydropteroate synthase inhibitor | |||
| 0.168 | 0.123 | 0.168 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.057 | 0.012 | 0.057 | Dihydrofolate reductase inhibitor | |||
| 0.083 | 0.039 | 0.083 | MAP kinase kinase 7 inhibitor | 0.083 0.038 DBMET01621 0.081 0.043 DBMET01622 | ||
| 0.071 | 0.029 | 0.071 | Argininosuccinate synthase inhibitor | |||
| 0.079 | 0.039 | 0.079 | CDK1/cyclin B1 inhibitor | |||
| 0.118 | 0.078 | 0.118 | Cathepsin H inhibitor | |||
| 0.059 | 0.021 | 0.059 | Potassium channel (Inward rectifier) activator | 0.053 0.03 DBMET01622 | ||
| 0.044 | 0.007 | 0.048 | CXC chemokine 2 receptor antagonist | 0.039 0.008 DBMET01621 0.048 0.006 DBMET01622 | DBMET01622 | |
| 0.056 | 0.02 | 0.056 | Potassium channel (ATP-sensitive) activator | 0.05 0.029 DBMET01622 | ||
| 0.076 | 0.041 | 0.076 | Phospholipase D inhibitor | |||
| 0.058 | 0.024 | 0.058 | Phosphodiesterase 7A inhibitor | |||
| 0.098 | 0.066 | 0.232 | MAO A inhibitor | 0.232 0.023 DBMET01621 0.203 0.028 DBMET01622 | DBMET01621 | |
| 0.05 | 0.018 | 0.05 | Histamine H1 receptor agonist | |||
| 0.096 | 0.064 | 0.14 | Creatine kinase inhibitor | 0.14 0.028 DBMET01621 0.135 0.031 DBMET01622 | DBMET01621 | |
| 0.179 | 0.147 | 0.338 | Streptokinase A inhibitor | 0.318 0.072 DBMET01621 0.338 0.066 DBMET01622 | DBMET01622 | |
| 0.056 | 0.024 | 0.056 | Adenosine deaminase inhibitor | |||
| 0.052 | 0.02 | 0.052 | AICAR transformylase inhibitor | |||
| 0.063 | 0.033 | 0.063 | Cyclin A1 inhibitor | |||
| 0.032 | 0.003 | 0.032 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.01 DBMET01621 0.019 0.01 DBMET01622 | ||
| 0.069 | 0.04 | 0.069 | Cyclin A2 inhibitor | |||
| 0.072 | 0.043 | 0.072 | Protein kinase C beta inhibitor | |||
| 0.173 | 0.144 | 0.173 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.032 | 0.003 | 0.032 | O6-alkylguanine-DNA alkyltransferase inhibitor | |||
| 0.264 | 0.236 | 0.306 | Caspase 9 stimulant | 0.306 0.187 DBMET01621 0.29 0.205 DBMET01622 | DBMET01621 | |
| 0.098 | 0.07 | 0.098 | Adenylate kinase inhibitor | |||
| 0.035 | 0.008 | 0.043 | Thymidine phosphorylase inhibitor | 0.036 0.008 DBMET01621 0.043 0.006 DBMET01622 | DBMET01622 | |
| 0.087 | 0.061 | 0.087 | NADH dehydrogenase inhibitor | |||
| 0.072 | 0.047 | 0.072 | Phosphofructokinase-1 inhibitor | |||
| 0.09 | 0.065 | 0.09 | Protein kinase C zeta inhibitor | 0.083 0.079 DBMET01621 | ||
| 0.1 | 0.076 | 0.115 | DOPA decarboxylase inhibitor | 0.114 0.052 DBMET01621 0.115 0.051 DBMET01622 | DBMET01622 | |
| 0.056 | 0.032 | 0.056 | Histamine agonist | |||
| 0.032 | 0.009 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.096 | 0.075 | 0.096 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.073 | 0.052 | 0.073 | Glutamate dehydrogenase inhibitor | |||
| 0.073 | 0.053 | 0.073 | Porphobilinogen synthase inhibitor | 0.064 0.062 DBMET01622 | ||
| 0.05 | 0.03 | 0.05 | Histamine H4 receptor antagonist | |||
| 0.089 | 0.069 | 0.089 | CDK2/cyclin A inhibitor | |||
| 0.111 | 0.092 | 0.111 | Phosphodiesterase inhibitor | |||
| 0.044 | 0.024 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.024 DBMET01621 0.051 0.013 DBMET01622 | DBMET01622 | |
| 0.185 | 0.165 | 0.21 | Tyrosine 3 hydroxylase inhibitor | 0.195 0.144 DBMET01621 0.21 0.119 DBMET01622 | DBMET01622 | |
| 0.158 | 0.139 | 0.158 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.05 | 0.032 | 0.05 | Antimetabolite | |||
| 0.126 | 0.108 | 0.126 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.02 | 0.002 | 0.02 | DNA topoisomerase III inhibitor | 0.008 0.005 DBMET01621 0.009 0.004 DBMET01622 | ||
| 0.038 | 0.021 | 0.038 | Fumarate hydratase inhibitor | |||
| 0.083 | 0.066 | 0.083 | Hematopoietic | |||
| 0.093 | 0.078 | 0.093 | mTOR complex 1 inhibitor | |||
| 0.154 | 0.14 | 0.159 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.129 DBMET01621 0.157 0.132 DBMET01622 | DBMET01621 | |
| 0.044 | 0.03 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.138 | 0.124 | 0.138 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.223 | 0.21 | 0.223 | DNA directed DNA polymerase inhibitor | |||
| 0.041 | 0.028 | 0.041 | Nicotinic acid receptor 1 agonist | |||
| 0.131 | 0.118 | 0.131 | Heat shock protein 70 antagonist | |||
| 0.075 | 0.063 | 0.075 | TIE-2 antagonist | |||
| 0.075 | 0.064 | 0.075 | TIE antagonist | |||
| 0.087 | 0.076 | 0.087 | Toll-Like receptor 3 antagonist | |||
| 0.054 | 0.043 | 0.054 | Immunoglobulin Fc receptor antagonist | |||
| 0.057 | 0.047 | 0.057 | Cyclin A inhibitor | |||
| 0.064 | 0.054 | 0.064 | Glutamate (mGluR6) antagonist | |||
| 0.012 | 0.003 | 0.012 | Phosphoribosylglycinamide formyltransferase inhibitor | |||
| 0.014 | 0.005 | 0.014 | Purine nucleoside phosphorylase inhibitor | |||
| 0.11 | 0.102 | 0.11 | Ribosomal protein S6 kinase inhibitor | |||
| 0.122 | 0.115 | 0.122 | Hexokinase inhibitor | |||
| 0.033 | 0.025 | 0.033 | Protein kinase C beta I inhibitor | |||
| 0.056 | 0.05 | 0.083 | Potassium channel (Ca-activated) blocker | 0.083 0.016 DBMET01621 0.08 0.018 DBMET01622 | DBMET01621 | |
| 0.027 | 0.022 | 0.027 | DNA polymerase III inhibitor | |||
| 0.053 | 0.048 | 0.053 | Biliverdin reductase inhibitor | |||
| 0.037 | 0.032 | 0.037 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.034 | 0.03 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.017 | 0.013 | 0.017 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.037 | 0.033 | 0.037 | AMPA 4 receptor antagonist | |||
| 0.054 | 0.051 | 0.054 | Alpha 2 adrenoreceptor agonist | |||
| 0.114 | 0.111 | 0.114 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.078 | 0.076 | 0.078 | Fibroblast growth factor 1 antagonist | |||
| 0.044 | 0.042 | 0.044 | Adenosine A2b receptor antagonist | |||
| 0.053 | 0.052 | 0.053 | Adenosine A2a receptor antagonist | |||
| 0.062 | 0.061 | 0.062 | I kappa B kinase 1 inhibitor | |||
| 0.044 | 0.044 | 0.046 | Dopamine beta hydroxylase inhibitor | 0.046 0.039 DBMET01622 | DBMET01622 | |
| 0.091 | 0.101 | 0.176 | MAO inhibitor | 0.176 0.049 DBMET01621 0.156 0.058 DBMET01622 | DBMET01621 | |
| 0.078 | 0.097 | 0.085 | Xanthine oxidase inhibitor | 0.085 0.081 DBMET01621 0.084 0.083 DBMET01622 | DBMET01621 | |
| 0.062 | 0.09 | 0.072 | Carbonic anhydrase VI inhibitor | 0.071 0.07 DBMET01621 0.072 0.069 DBMET01622 | DBMET01622 | |
| 0.053 | 0.082 | 0.155 | CXC chemokine receptor antagonist | 0.137 0.013 DBMET01621 0.155 0.01 DBMET01622 | DBMET01622 | |
| 0.16 | 0.194 | 0.292 | 12-Lipoxygenase inhibitor | 0.292 0.084 DBMET01621 0.282 0.091 DBMET01622 | DBMET01621 | |
| 0.052 | 0.086 | 0.068 | Glutamate decarboxylase inhibitor | 0.068 0.058 DBMET01622 | DBMET01622 | |
| 0.169 | 0.211 | 0.206 | Insulysin inhibitor | 0.199 0.159 DBMET01621 0.206 0.148 DBMET01622 | DBMET01622 | |
| 0.071 | 0.136 | 0.175 | M18 aspartyl aminopeptidase inhibitor | 0.175 0.042 DBMET01621 0.161 0.047 DBMET01622 | DBMET01621 | |
| 0.023 | 0.094 | 0.041 | NMDA receptor subunit 3B antagonist | 0.041 0.034 DBMET01621 0.04 0.035 DBMET01622 | DBMET01621 | |
| 0.079 | 0.157 | 0.116 | Alkaline phosphatase inhibitor | 0.11 0.1 DBMET01621 0.116 0.091 DBMET01622 | DBMET01622 | |
| 0.064 | 0.142 | 0.133 | Cystathionine beta-synthase inhibitor | 0.133 0.049 DBMET01621 0.126 0.053 DBMET01622 | DBMET01621 | |
| 0.039 | 0.135 | 0.081 | MAO B inhibitor | 0.081 0.075 DBMET01621 | DBMET01621 | |
| 0.064 | 0.163 | 0.105 | Beta glucuronidase inhibitor | 0.105 0.063 DBMET01621 0.101 0.069 DBMET01622 | DBMET01621 | |
| 0.139 | 0.239 | 0.203 | Hypoxia-inducible factor 1 alpha inhibitor | 0.203 0.148 DBMET01621 0.192 0.162 DBMET01622 | DBMET01621 | |
| 0.142 | 0.281 | 0.336 | 15-Lipoxygenase inhibitor | 0.336 0.107 DBMET01621 0.321 0.117 DBMET01622 | DBMET01621 | |
| 0.016 | 0.16 | 0.041 | Estrogen-related receptor beta antagonist | 0.041 0.01 DBMET01621 0.038 0.013 DBMET01622 | DBMET01621 | |
| 0.035 | 0.18 | 0.079 | Potassium channel (Ca-activated) activator | 0.079 0.076 DBMET01622 | DBMET01622 | |
| 0.08 | 0.255 | 0.15 | Aldehyde oxidase inhibitor | 0.15 0.139 DBMET01621 | DBMET01621 | |
| 0.05 | 0.258 | 0.148 | Nav1.1 sodium channel blocker | 0.145 0.035 DBMET01621 0.148 0.034 DBMET01622 | DBMET01622 | |
| 0.03 | 0.246 | 0.054 | Cathepsin E inhibitor | 0.054 0.052 DBMET01622 | DBMET01622 | |
| 0.021 | 0.33 | 0.099 | Topoisomerase I inhibitor | 0.099 0.071 DBMET01621 | DBMET01621 | |
| 0.019 | 0.423 | 0.107 | Topoisomerase II inhibitor | 0.107 0.08 DBMET01621 0.095 0.091 DBMET01622 | DBMET01621 | |
| 0.005 | 0.786 | 0.107 | Estrogen receptor beta antagonist | 0.107 0.051 DBMET01621 0.103 0.059 DBMET01622 | DBMET01621 | |
| 0.004 | 0.914 | 0.109 | Estrogen antagonist | 0.109 0.077 DBMET01621 0.102 0.092 DBMET01622 | DBMET01621 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |